Liquidia (NASDAQ:LQDA) CAO Dana Boyle Sells 1,581 Shares of Stock

Liquidia Corporation (NASDAQ:LQDA) CAO Dana Boyle sold 1,581 shares of the stock in a transaction that occurred on Monday, October 26th. The stock was sold at an average price of $43.19, for a total value of $68,283.39. Following the completion of the sale, the chief accounting officer owned 164,028 shares of the company’s stock, valued at approximately $7,084,369.32. This trade represents a 0.95% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Dana Boyle also recently made the following trade(s):

• On Monday, October 12th, Dana Boyle sold 5,892 shares of Liquidia stock. The stock was sold at an average price of $28.48, for a total value of $167,804.16.

Liquidia Price Performance

LQDA opened at $45.72 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.12 and a current ratio of 2.31. Liquidia Corporation has a 52-week low of $22.05 and a 52-week high of $93.61. The stock has a market capitalization of $4.09 billion, a PE ratio of 33.37, a price-to-earnings-growth ratio of 0.37 and a beta of 0.61. The stock’s 50 day moving average price is $54.12 and its 200-day moving average price is $54.22.

Liquidia (NASDAQ:LQDA) last announced its earnings results on Wednesday, August 12th. The company reported $0.74 EPS for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The business had revenue of $171.68 million for the quarter, compared to the consensus estimate of $168.48 million. During the same quarter in the prior year, the company earned ($0.49) EPS. Liquidia’s revenue was up 1842.1% compared to the same quarter last year. On average, equities research analysts predict that Liquidia Corporation will post 2.05 EPS for the current year.

Analysts Set New Price Targets

LQDA has been the topic of a number of research analyst reports. Stephens set a $130.00 price objective on shares of Liquidia in a research report on Friday, July 24th. Zacks Research lowered shares of Liquidia from a “hold” rating to a “strong sell” rating in a report on Tuesday, September 22nd. HC Wainwright raised their target price on shares of Liquidia from $58.00 to $65.00 and gave the stock a “buy” rating in a research report on Thursday, October 15th. BTIG Research raised shares of Liquidia from a “neutral” rating to a “buy” rating and set a $70.00 target price on the stock in a research note on Wednesday, October 14th. Finally, Jefferies Financial Group upgraded shares of Liquidia to a “strong-buy” rating in a research report on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $72.85.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in LQDA. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its position in Liquidia by 12.3% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 17,400 shares of the company’s stock valued at $527,000 after buying an additional 1,900 shares during the period. Hanseatic Management Services Inc. boosted its holdings in shares of Liquidia by 2.0% during the 3rd quarter. Hanseatic Management Services Inc. now owns 21,733 shares of the company’s stock valued at $658,000 after buying an additional 435 shares in the last quarter. Pinnacle Wealth Planning Services Inc. boosted its holdings in shares of Liquidia by 26.2% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company’s stock valued at $47,000 after buying an additional 323 shares in the last quarter. Bryant Woods Investment Advisors LLC boosted its holdings in shares of Liquidia by 47.4% during the 3rd quarter. Bryant Woods Investment Advisors LLC now owns 12,677 shares of the company’s stock valued at $384,000 after buying an additional 4,077 shares in the last quarter. Finally, Sterling Capital Management LLC grew its position in shares of Liquidia by 839.1% in the 3rd quarter. Sterling Capital Management LLC now owns 2,329 shares of the company’s stock worth $70,000 after buying an additional 2,081 shares during the period. Institutional investors own 64.54% of the company’s stock.

Liquidia Company Profile

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.

Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.